s marks a historic decision because this was the first time cannabis has ever been subject to a critical review conducted by the WHO. In March 2019, the Commission on Narcotic Drugs, comprised of 53 countries, will vote on the WHO's recommendations to schedule substances. A simple majority is required. However, it is uncertain wh